In this follow-up episode of the BioVentures Podcast, Dr. John Sherrill explores what happens after intellectual property (IP) is disclosed and protected. Dr. Sherrill breaks down the commercialization journey—from marketing patented technologies and identifying licensees to navigating license types and supporting faculty-led startups. He shares real-world insight into option agreements, exclusive vs. non-exclusive licenses, and how researchers can choose between launching a startup or licensing their invention. If you're a UAMS researcher curious about the next steps in tech transfer, this episode is packed with practical guidance and encouragement.